Clinical Trial Update: Intensified 1st Cycle Rituximab Plus 8th Cycles of R-CHOP Chemotherapy in Patients With Advanced or Bulky CD20+ Diffuse Large B-cell Lymphoma (DLBCL) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating intensified first-cycle Rituximab followed by eight cycles of R-CHOP chemotherapy in patients with advanced or bulky CD20-positive di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Samsung Medical Center | Conditions: Diffuse Large B-cell Lymphoma (DLBCL) | Phase 2 | Status: COMPLETED